Friday, November 20, 2026

Wontech Invests 10.8 Billion Won in Japanese Hair-Loss Clinic Acquisition... Secures Equipment Supply Chain

Input
2026-11-20 08:41:49
Updated
2026-11-20 08:41:49
[Financial News] Laser- and energy-based medical device company Wontech has launched an equity investment worth 10.8 billion won to target Japan’s hair-loss treatment market. Its strategy is to participate in the acquisition of a medical corporation with a network of local clinics specializing in hair-loss treatment, securing customers for its medical devices and expanding its business in Japan.
Wontech said on the 20th that it had invested, alongside Korean private equity (PEF) manager Invictus Private Equity Asia and Taekwang Industrial, in a special-purpose company (SPC) acquiring Japanese medical corporation Nisshokai and hospital management support company (MSO) Nissho Medical.
Doctor AGA Clinic, a hair-loss treatment specialist clinic operated by Nisshokai, has 15 locations in major Japanese cities including Tokyo and Osaka. By securing a local medical network, Wontech aims to move beyond its previous sales approach, which focused on individual hospitals and clinics, and establish a stable foundation for equipment supply.
The growth potential of Japan’s hair-loss treatment market is also cited as a reason for the investment. According to global market research firm Grand View Research, Japan’s alopecia market is projected to grow by about 49.4%, from about $3.43 billion in 2025 to $5.12 billion in 2033.
Wontech plans to firm up equipment-supply cooperation with Nisshokai and Nissho Medical and, after completing local regulatory approval procedures, supply laser medical devices to the clinic chain. The company expects this to lay the groundwork for expanding sales in Japan, as it can secure large-scale customers rather than rely on sales to individual hospitals and clinics.
In particular, Doctor AGA Clinic is set to expand to 25 locations by 2029, creating expectations for additional equipment supply opportunities. Wontech plans to broaden its product range while securing both business results from medical device sales and medium- to long-term financial returns through its equity investment.
A Wontech representative said, “This investment is a strategic decision to expand the foundation for medical device supply in Japan,” adding, “Through cooperation with local clinic chains, we will expand the basis for laser equipment sales and strengthen our position in the Japanese market.”

[email protected] Jung Sang-hee Reporter